Positron Corporation (POSC)

[crammerfool]

Bayou Man, That was originally on 5/21, now_updated.

I see they are re-releasing news again from 5/21, just like I was showing yesterday on another news release about them.

There are probably a few updates as I have not compared todays' to May 21st release.

=========================================================================

http://www.mmdnewswire.com/imagin-molecular-corporation-8551.html

IMAGIN MOLECULAR CORPORATION ACQUIRES AN INVESTMENT POSITION IN POSITRON CORPORATION CURRENTLY VALUED AT $35 MILLION

Chicago, IL (MMD Newswire) May 21, 2010 -- The Board and Shareholders of Imagin Molecular Corporation ("IMGM") have approved certain transactions wherein IMGM completed the acquisition of 3,100,000 Class B Preferred Shares of Positron Corporation which shares are convertible on a one for 100 basis into Positron common shares and therefore currently have a value marked to the current market price for Positron Corporation common shares of in excess of $35 million assuming conversion into commons stock. It is IMGM's current intention to hold the Positron Class B Preferred shares for investment purposes. The consideration for the purchase of the Positron investment position is the issuance of 310,000,000 common shares of IMGM to IMAGIN Diagnostic Centres, Inc. (IDC) a private Canadian company that is in the PET scanning business in Canada and a historical owner 3,100,000 Class B preferred strategic block equity position. IMGM simultaneously will announce its intent to build Cardiac Disease Reversal and Prevention Clinics across Canada and, after initial success, across the USA and globally. The new subsidiary will be named "Positron Cardiac CARE Clinics".
Currently IMGM will hold almost one Positron common share equivalent for each IMGM common share outstanding when the current investment of POSC shares is added to a stock position of 76,235,800 POSC common shares held historically by IMGM. IMGM will own assuming conversion to POSC common stock 386,235,800 Positron common share equivalents. IMGM upon completion of this transaction will have 405,000,000 common shares outstanding with no significant debt or preferred stock outstanding.

About Imagin Molecular Corporation:

Imagin Molecular Corporation (IMGM) is a company dedicated to socially responsible issues. IMGM main areas of interest are focused on medical and environmental. IMGM through its subsidiary Positron Cardiac CARE Clinics ("PCCC") is planning to open Cardiac Disease Reversal Clinics across Canada and after initial success across the USA and globally.

IMGM through a newly to-be-formed 51% owned subsidiary The Planet Green Bottle Corporation has developed and is introducing globally through a subsidiary, the world's first and only oxo-biodegradable PET (polyethylene terephthalate) plastic bottle. The Planet Green oxo-biodegradable technology was developed by Wells Plastics Ltd of the UK and is proprietary with patent pending trademarked by Wells as Reverte.

Imagin Molecular Corporation strategy and focus in its medical segment is dedicated to capitalizing on opportunities in positron emission tomography (PET) directed toward the diagnosis of cancer, heart disease and neurological diseases. PET is an advanced medical diagnostic imaging procedure used by physicians in the detection of certain cancers, coronary disease and neurological disorders including Alzheimer's disease. IMAGIN Molecular Corporation has a large strategic equity block position in Positron Corporation. The Positron technology is considered to be the gold standard for cardiac disease diagnosis.

About Planet Green Bottle Corporation

Planet Green Bottle Corporation ("PGBC") initiated with Wells Plastics Ltd. of the UK, the development of a masterbatch additive which causes a PET plastic bottle to become oxo-biodegradable in the environment. The Planet Green concept is to promote its "The PLANET BOTTLE" logo as a brand enhancer wherein the consumer will search for "The PLANET BOTTLE" logo on a brand owner's label as a sign that the plastic bottles and packaging are eco-friendly and will oxo-biodegrade over 10-20 years as opposed to perhaps over 1,000 years for non-treated PET plastic. Planet Green markets its product to brand owners globally. Planet Green is also working with governmental agencies around the world in order to influence legislation mandating that all plastics be treated with oxo-biodegradable additives as a step toward curtailing the pollution of the Planet with Plastic. IMGM acquired the proprietary position and intellectual property of PGBC of Canada in exchange for giving up a 49% interest in its corporate venture to be also called PGBC, a Delaware-incorporated subsidiary.

Contact:

Patrick Rooney
Director of Corporate Development
[e-mail]

###